Geron | GERN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Amgen USD 9.19B 532M 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
Cassava Sciences USD 68.14M 6.26M 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Genmab DKK 5.85B 96M 2025-12
Geron USD 229.11M 3.24M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 5.62B 455.37M 2026-03
MacroGenics USD 21.2M 34.39M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Novavax USD -144.76M 17.01M 2026-03